SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,403,163 | +219.3% | 201,313 | +201.7% | 0.03% | +244.4% |
| Q2 2023 | $7,642,377 | +10.1% | 66,734 | +32.5% | 0.01% | 0.0% |
| Q1 2023 | $6,942,359 | -9.5% | 50,369 | -14.9% | 0.01% | -18.2% |
| Q4 2022 | $7,668,415 | +45.6% | 59,179 | +24.2% | 0.01% | +37.5% |
| Q3 2022 | $5,265,241 | +96.8% | 47,632 | +33.5% | 0.01% | +14.3% |
| Q2 2022 | $2,675,000 | -15.3% | 35,687 | -11.7% | 0.01% | 0.0% |
| Q1 2022 | $3,159,000 | -14.9% | 40,438 | -1.9% | 0.01% | 0.0% |
| Q4 2021 | $3,714,000 | +66.5% | 41,239 | +71.0% | 0.01% | +75.0% |
| Q3 2021 | $2,230,000 | +16.6% | 24,111 | -2.0% | 0.00% | 0.0% |
| Q2 2021 | $1,913,000 | +2.9% | 24,607 | -1.3% | 0.00% | 0.0% |
| Q1 2021 | $1,859,000 | -59.0% | 24,942 | -6.1% | 0.00% | -55.6% |
| Q4 2020 | $4,530,000 | +16.8% | 26,568 | -3.8% | 0.01% | 0.0% |
| Q3 2020 | $3,877,000 | -15.8% | 27,609 | -3.9% | 0.01% | -18.2% |
| Q2 2020 | $4,605,000 | +86.6% | 28,719 | +13.8% | 0.01% | +57.1% |
| Q1 2020 | $2,468,000 | -27.0% | 25,228 | -3.7% | 0.01% | 0.0% |
| Q4 2019 | $3,381,000 | +17.9% | 26,204 | -31.2% | 0.01% | +16.7% |
| Q3 2019 | $2,867,000 | -45.3% | 38,062 | +10.3% | 0.01% | -45.5% |
| Q2 2019 | $5,243,000 | +37.6% | 34,509 | +7.9% | 0.01% | +22.2% |
| Q1 2019 | $3,811,000 | -10.5% | 31,970 | -18.1% | 0.01% | -18.2% |
| Q4 2018 | $4,258,000 | -18.6% | 39,012 | +20.4% | 0.01% | 0.0% |
| Q3 2018 | $5,234,000 | +16.8% | 32,407 | -4.4% | 0.01% | +10.0% |
| Q2 2018 | $4,481,000 | -83.5% | 33,907 | -90.7% | 0.01% | -82.8% |
| Q1 2018 | $27,095,000 | -13.0% | 365,695 | -34.7% | 0.06% | -10.8% |
| Q4 2017 | $31,151,000 | +9.2% | 559,874 | -11.0% | 0.06% | +6.6% |
| Q3 2017 | $28,535,000 | +48.9% | 629,053 | +10.6% | 0.06% | +41.9% |
| Q2 2017 | $19,165,000 | +3187.3% | 568,525 | +2786.1% | 0.04% | +4200.0% |
| Q1 2017 | $583,000 | +8.0% | 19,699 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $540,000 | -51.8% | 19,699 | +8.1% | 0.00% | -50.0% |
| Q3 2016 | $1,120,000 | +221.8% | 18,231 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $348,000 | -2.2% | 18,231 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $356,000 | -49.4% | 18,231 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $703,000 | +20.2% | 18,231 | 0.0% | 0.00% | +100.0% |
| Q3 2015 | $585,000 | -11.0% | 18,231 | -15.6% | 0.00% | -50.0% |
| Q2 2015 | $657,000 | +119.7% | 21,599 | -4.1% | 0.00% | +100.0% |
| Q1 2015 | $299,000 | -8.3% | 22,534 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $326,000 | -31.4% | 22,534 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $475,000 | -29.2% | 22,534 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $671,000 | +35.6% | 22,534 | +9.5% | 0.00% | +100.0% |
| Q1 2014 | $495,000 | +18.1% | 20,586 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $419,000 | -53.5% | 20,586 | +8.0% | 0.00% | -50.0% |
| Q3 2013 | $901,000 | +23.6% | 19,069 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $729,000 | – | 19,069 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |